share_log

AEON Biopharma | 8-K: AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results

SEC ·  Mar 30 03:48
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.